4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-18-000981
Director sold 72,934 shares at an average $29.85 ($2,176,898)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-17 | Sale : show line 1 in the form | −3,009 | $33.17 | $99,797 | 1,234,193 | I |
| 2018-12-18 | Sale : show line 2 in the form | −69,925 | $29.70 | $2,077,101 | 1,164,268 | I |
| Open-market sales · 72,934 sh · avg $29.85 · $2,176,898 | ||||||
Loading xslF345X03/crisprfm4_dec172018.xml…